Co-proxamol

Co-proxamol

Combination of
Dextropropoxyphene	Opioid analgesic
Paracetamol	Non-opioid analgesic
[[{{{component3}}}]]	? Class
[[{{{component4}}}]]	? Class
[[{{{component5}}}]]	? Class
[[{{{component6}}}]]	? Class
Gene therapy
Clinical data
Routes of administration	Oral
Physiological data
Legal status
Pharmacokinetic data
Identifiers
CAS Number	39400-85-6
PubChem Template:Abbreviation	123857
Chemical and physical data

Co-proxamol (BAN, also coproxamol) is a combination of the analgesics dextropropoxyphene (an opioid) and paracetamol.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) decided in 2005 to withdraw co-proxamol from the market following advice from the Committee on Safety of Medicines (CSM) that co-proxamol is little more effective than paracetamol alone as an analgesic, but that it was associated with higher fatality rates if a drug overdose were intentionally or inadvertently taken. The decision provoked some outcry from long-term users of the drug.

References

• "Suicide painkiller withdrawn". The Times. January 31, 2005.
• "Painkiller scrapped over suicides". BBC News. January 31, 2005.
• "Co-proxamol to be withdrawn from the market". Medicines and Healthcare products Regulatory Agency. 31 January 2005.
• "Withdrawal of co-proxamol". Medicines and Healthcare products Regulatory Agency. 17 January 2007.